Pacific BioLabs works hard to be The Service Leader in Bioscience Testing, and nothing makes us more proud then receiving […]

Pacific BioLabs clients are on the cutting edge of developing novel therapeutic approaches to target unmet medical needs.  Nine Continents […]

The International Organization of Standardization (ISO) is an independent, non-governmental international organization with a membership of 165 national standards bodies. […]

Pacific BioLabs has recently completed validation of an expanded panel of general clinical chemistry readouts using its Siemens Dimension® Xpand […]

As an essential business, Pacific BioLabs has remained open during the Shelter in Place order and continued delivering testing services […]

Pacific BioLabs would like to reassure its clients that we are continuing core operations at the moment and continue to […]

On 21 January 2020, Pacific BioLabs received unconditional approval for continuance of our ISO 17025:2017 accreditation, General Requirements for the […]

PBL clients are at the forefront of identifying new targets for drug discovery and development. Ophirex, a San Francisco Bay […]

Pacific BioLabs has purchased a new Sciex Triple Quad 6500+ LC-MS/MS. This instrument is a great addition to our existing […]

The United States Pharmacopeia (USP) has published a new general chapter, the USP <60> which will become official on December […]